Approximate numbers of incident cases of some exemplar conditions expected to accrue during the first 20 years of follow-up in UK Biobank.

<p>Based on UK age- and sex-specific rates with adjustment for healthy cohort effects and losses to follow-up [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001779#pmed.1001779.ref006" target="_blank">6</a>].</p><p>MI: myocardial infarction; COPD: chronic obstructive pulmonary disease or chronic bronchitis/emphysema</p><p>Approximate numbers of incident cases of some exemplar conditions expected to accrue during the first 20 years of follow-up in UK Biobank.</p

Data collected at the baseline assessment.

<p>* assessed in 170,000 participants;</p><p>^† assessed in 50,000 participants;</p><p>^‡measured in one heel for 170,000 participants and in both heels for 320,000 participants;</p><p>^¶ measured in 170,000 participants;</p><p>^§ measured in 100,000 participants</p><p>Data collected at the baseline assessment.</p

Current and planned future data available in the UK Biobank resource.

<p>Hb: haemoglobin; SNPs: single nucleotide polymorphisms; CNV: copy number variations; MRI: magnetic resonance imaging; DXA: dual-energy X-ray absorptiometry; ICD: International Classification of Diseases; OPCS: Office of Population Censuses and Surveys Classification of Interventions and Procedures</p><p>^‡ Future dates are estimated. Data available may be all or part of the relevant dataset.</p><p>* available from an earlier date from health record systems in Scotland</p><p>Current and planned future data available in the UK Biobank resource.</p

Additional file 1: of The UAE healthy future study: a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals

Participant Completed Questionnaire. (DOCX 82 kb